Research ArticleArticle
Fat Infiltration on Magnetic Resonance Imaging of the Sacroiliac Joints Has Limited Diagnostic Utility in Nonradiographic Axial Spondyloarthritis
Ulrich Weber, Susanne J. Pedersen, Veronika Zubler, Kaspar Rufibach, Stanley M. Chan, Robert G.W. Lambert, Mikkel Østergaard and Walter P. Maksymowych
The Journal of Rheumatology December 2013, jrheum.130568; DOI: https://doi.org/10.3899/jrheum.130568
Ulrich Weber
From the Department of Rheumatology and the Department of Radiology, Balgrist University Hospital, Zurich, Switzerland; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spinal Diseases, University of Copenhagen, Copenhagen, Denmark; Rufibach rePROstat, Basel, Switzerland; Department of Ophthalmology, the Department of Radiology and Diagnostic Imaging, and the Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. Supported by The Canadian Arthritis Society National Research Initiative Award, the Alberta Innovates Health Solutions, and the Walter L. and Johanna Wolf Foundation, Zurich, Switzerland. Dr. Rufibach is founder and owner of Rufibach rePROstat and is an employee of F. Hoffmann-La Roche, Basel, Switzerland. Dr. Maksymowych is a Scientist of Alberta Innovates Health Solutions. U. Weber, MD, Department of Medicine, University of Alberta, Department of Rheumatology, Balgrist University Hospital; S.J. Pedersen, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spinal Diseases, University of Copenhagen; V. Zubler, MD, Department of Radiology, Balgrist University Hospital; K. Rufibach, PhD, Rufibach rePROstat; S.M. Chan, MD, FRCSC, Department of Ophthalmology, University of Alberta; R.G.W. Lambert, MB, FRCPC, M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spinal Diseases, University of Copenhagen; W.P. Maksymowych, MB, FRCPC, Department of Medicine, University of Alberta. Address correspondence to Dr. U. Weber, Department of Rheumatology, Balgrist University Hospital, Forchstrasse 340, 8008 Zurich, Switzerland. E-mail: ulrich.weber02@bluewin.ch. Accepted for publication September 17, 2013.
Susanne J. Pedersen
From the Department of Rheumatology and the Department of Radiology, Balgrist University Hospital, Zurich, Switzerland; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spinal Diseases, University of Copenhagen, Copenhagen, Denmark; Rufibach rePROstat, Basel, Switzerland; Department of Ophthalmology, the Department of Radiology and Diagnostic Imaging, and the Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. Supported by The Canadian Arthritis Society National Research Initiative Award, the Alberta Innovates Health Solutions, and the Walter L. and Johanna Wolf Foundation, Zurich, Switzerland. Dr. Rufibach is founder and owner of Rufibach rePROstat and is an employee of F. Hoffmann-La Roche, Basel, Switzerland. Dr. Maksymowych is a Scientist of Alberta Innovates Health Solutions. U. Weber, MD, Department of Medicine, University of Alberta, Department of Rheumatology, Balgrist University Hospital; S.J. Pedersen, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spinal Diseases, University of Copenhagen; V. Zubler, MD, Department of Radiology, Balgrist University Hospital; K. Rufibach, PhD, Rufibach rePROstat; S.M. Chan, MD, FRCSC, Department of Ophthalmology, University of Alberta; R.G.W. Lambert, MB, FRCPC, M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spinal Diseases, University of Copenhagen; W.P. Maksymowych, MB, FRCPC, Department of Medicine, University of Alberta. Address correspondence to Dr. U. Weber, Department of Rheumatology, Balgrist University Hospital, Forchstrasse 340, 8008 Zurich, Switzerland. E-mail: ulrich.weber02@bluewin.ch. Accepted for publication September 17, 2013.
Veronika Zubler
From the Department of Rheumatology and the Department of Radiology, Balgrist University Hospital, Zurich, Switzerland; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spinal Diseases, University of Copenhagen, Copenhagen, Denmark; Rufibach rePROstat, Basel, Switzerland; Department of Ophthalmology, the Department of Radiology and Diagnostic Imaging, and the Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. Supported by The Canadian Arthritis Society National Research Initiative Award, the Alberta Innovates Health Solutions, and the Walter L. and Johanna Wolf Foundation, Zurich, Switzerland. Dr. Rufibach is founder and owner of Rufibach rePROstat and is an employee of F. Hoffmann-La Roche, Basel, Switzerland. Dr. Maksymowych is a Scientist of Alberta Innovates Health Solutions. U. Weber, MD, Department of Medicine, University of Alberta, Department of Rheumatology, Balgrist University Hospital; S.J. Pedersen, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spinal Diseases, University of Copenhagen; V. Zubler, MD, Department of Radiology, Balgrist University Hospital; K. Rufibach, PhD, Rufibach rePROstat; S.M. Chan, MD, FRCSC, Department of Ophthalmology, University of Alberta; R.G.W. Lambert, MB, FRCPC, M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spinal Diseases, University of Copenhagen; W.P. Maksymowych, MB, FRCPC, Department of Medicine, University of Alberta. Address correspondence to Dr. U. Weber, Department of Rheumatology, Balgrist University Hospital, Forchstrasse 340, 8008 Zurich, Switzerland. E-mail: ulrich.weber02@bluewin.ch. Accepted for publication September 17, 2013.
Kaspar Rufibach
From the Department of Rheumatology and the Department of Radiology, Balgrist University Hospital, Zurich, Switzerland; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spinal Diseases, University of Copenhagen, Copenhagen, Denmark; Rufibach rePROstat, Basel, Switzerland; Department of Ophthalmology, the Department of Radiology and Diagnostic Imaging, and the Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. Supported by The Canadian Arthritis Society National Research Initiative Award, the Alberta Innovates Health Solutions, and the Walter L. and Johanna Wolf Foundation, Zurich, Switzerland. Dr. Rufibach is founder and owner of Rufibach rePROstat and is an employee of F. Hoffmann-La Roche, Basel, Switzerland. Dr. Maksymowych is a Scientist of Alberta Innovates Health Solutions. U. Weber, MD, Department of Medicine, University of Alberta, Department of Rheumatology, Balgrist University Hospital; S.J. Pedersen, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spinal Diseases, University of Copenhagen; V. Zubler, MD, Department of Radiology, Balgrist University Hospital; K. Rufibach, PhD, Rufibach rePROstat; S.M. Chan, MD, FRCSC, Department of Ophthalmology, University of Alberta; R.G.W. Lambert, MB, FRCPC, M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spinal Diseases, University of Copenhagen; W.P. Maksymowych, MB, FRCPC, Department of Medicine, University of Alberta. Address correspondence to Dr. U. Weber, Department of Rheumatology, Balgrist University Hospital, Forchstrasse 340, 8008 Zurich, Switzerland. E-mail: ulrich.weber02@bluewin.ch. Accepted for publication September 17, 2013.
Stanley M. Chan
From the Department of Rheumatology and the Department of Radiology, Balgrist University Hospital, Zurich, Switzerland; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spinal Diseases, University of Copenhagen, Copenhagen, Denmark; Rufibach rePROstat, Basel, Switzerland; Department of Ophthalmology, the Department of Radiology and Diagnostic Imaging, and the Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. Supported by The Canadian Arthritis Society National Research Initiative Award, the Alberta Innovates Health Solutions, and the Walter L. and Johanna Wolf Foundation, Zurich, Switzerland. Dr. Rufibach is founder and owner of Rufibach rePROstat and is an employee of F. Hoffmann-La Roche, Basel, Switzerland. Dr. Maksymowych is a Scientist of Alberta Innovates Health Solutions. U. Weber, MD, Department of Medicine, University of Alberta, Department of Rheumatology, Balgrist University Hospital; S.J. Pedersen, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spinal Diseases, University of Copenhagen; V. Zubler, MD, Department of Radiology, Balgrist University Hospital; K. Rufibach, PhD, Rufibach rePROstat; S.M. Chan, MD, FRCSC, Department of Ophthalmology, University of Alberta; R.G.W. Lambert, MB, FRCPC, M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spinal Diseases, University of Copenhagen; W.P. Maksymowych, MB, FRCPC, Department of Medicine, University of Alberta. Address correspondence to Dr. U. Weber, Department of Rheumatology, Balgrist University Hospital, Forchstrasse 340, 8008 Zurich, Switzerland. E-mail: ulrich.weber02@bluewin.ch. Accepted for publication September 17, 2013.
Robert G.W. Lambert
From the Department of Rheumatology and the Department of Radiology, Balgrist University Hospital, Zurich, Switzerland; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spinal Diseases, University of Copenhagen, Copenhagen, Denmark; Rufibach rePROstat, Basel, Switzerland; Department of Ophthalmology, the Department of Radiology and Diagnostic Imaging, and the Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. Supported by The Canadian Arthritis Society National Research Initiative Award, the Alberta Innovates Health Solutions, and the Walter L. and Johanna Wolf Foundation, Zurich, Switzerland. Dr. Rufibach is founder and owner of Rufibach rePROstat and is an employee of F. Hoffmann-La Roche, Basel, Switzerland. Dr. Maksymowych is a Scientist of Alberta Innovates Health Solutions. U. Weber, MD, Department of Medicine, University of Alberta, Department of Rheumatology, Balgrist University Hospital; S.J. Pedersen, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spinal Diseases, University of Copenhagen; V. Zubler, MD, Department of Radiology, Balgrist University Hospital; K. Rufibach, PhD, Rufibach rePROstat; S.M. Chan, MD, FRCSC, Department of Ophthalmology, University of Alberta; R.G.W. Lambert, MB, FRCPC, M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spinal Diseases, University of Copenhagen; W.P. Maksymowych, MB, FRCPC, Department of Medicine, University of Alberta. Address correspondence to Dr. U. Weber, Department of Rheumatology, Balgrist University Hospital, Forchstrasse 340, 8008 Zurich, Switzerland. E-mail: ulrich.weber02@bluewin.ch. Accepted for publication September 17, 2013.
Mikkel Østergaard
From the Department of Rheumatology and the Department of Radiology, Balgrist University Hospital, Zurich, Switzerland; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spinal Diseases, University of Copenhagen, Copenhagen, Denmark; Rufibach rePROstat, Basel, Switzerland; Department of Ophthalmology, the Department of Radiology and Diagnostic Imaging, and the Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. Supported by The Canadian Arthritis Society National Research Initiative Award, the Alberta Innovates Health Solutions, and the Walter L. and Johanna Wolf Foundation, Zurich, Switzerland. Dr. Rufibach is founder and owner of Rufibach rePROstat and is an employee of F. Hoffmann-La Roche, Basel, Switzerland. Dr. Maksymowych is a Scientist of Alberta Innovates Health Solutions. U. Weber, MD, Department of Medicine, University of Alberta, Department of Rheumatology, Balgrist University Hospital; S.J. Pedersen, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spinal Diseases, University of Copenhagen; V. Zubler, MD, Department of Radiology, Balgrist University Hospital; K. Rufibach, PhD, Rufibach rePROstat; S.M. Chan, MD, FRCSC, Department of Ophthalmology, University of Alberta; R.G.W. Lambert, MB, FRCPC, M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spinal Diseases, University of Copenhagen; W.P. Maksymowych, MB, FRCPC, Department of Medicine, University of Alberta. Address correspondence to Dr. U. Weber, Department of Rheumatology, Balgrist University Hospital, Forchstrasse 340, 8008 Zurich, Switzerland. E-mail: ulrich.weber02@bluewin.ch. Accepted for publication September 17, 2013.
Walter P. Maksymowych
From the Department of Rheumatology and the Department of Radiology, Balgrist University Hospital, Zurich, Switzerland; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spinal Diseases, University of Copenhagen, Copenhagen, Denmark; Rufibach rePROstat, Basel, Switzerland; Department of Ophthalmology, the Department of Radiology and Diagnostic Imaging, and the Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. Supported by The Canadian Arthritis Society National Research Initiative Award, the Alberta Innovates Health Solutions, and the Walter L. and Johanna Wolf Foundation, Zurich, Switzerland. Dr. Rufibach is founder and owner of Rufibach rePROstat and is an employee of F. Hoffmann-La Roche, Basel, Switzerland. Dr. Maksymowych is a Scientist of Alberta Innovates Health Solutions. U. Weber, MD, Department of Medicine, University of Alberta, Department of Rheumatology, Balgrist University Hospital; S.J. Pedersen, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spinal Diseases, University of Copenhagen; V. Zubler, MD, Department of Radiology, Balgrist University Hospital; K. Rufibach, PhD, Rufibach rePROstat; S.M. Chan, MD, FRCSC, Department of Ophthalmology, University of Alberta; R.G.W. Lambert, MB, FRCPC, M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spinal Diseases, University of Copenhagen; W.P. Maksymowych, MB, FRCPC, Department of Medicine, University of Alberta. Address correspondence to Dr. U. Weber, Department of Rheumatology, Balgrist University Hospital, Forchstrasse 340, 8008 Zurich, Switzerland. E-mail: ulrich.weber02@bluewin.ch. Accepted for publication September 17, 2013.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Fat Infiltration on Magnetic Resonance Imaging of the Sacroiliac Joints Has Limited Diagnostic Utility in Nonradiographic Axial Spondyloarthritis
Ulrich Weber, Susanne J. Pedersen, Veronika Zubler, Kaspar Rufibach, Stanley M. Chan, Robert G.W. Lambert, Mikkel Østergaard, Walter P. Maksymowych
The Journal of Rheumatology Dec 2013, jrheum.130568; DOI: 10.3899/jrheum.130568
Fat Infiltration on Magnetic Resonance Imaging of the Sacroiliac Joints Has Limited Diagnostic Utility in Nonradiographic Axial Spondyloarthritis
Ulrich Weber, Susanne J. Pedersen, Veronika Zubler, Kaspar Rufibach, Stanley M. Chan, Robert G.W. Lambert, Mikkel Østergaard, Walter P. Maksymowych
The Journal of Rheumatology Dec 2013, jrheum.130568; DOI: 10.3899/jrheum.130568